Clovis Oncology Inc Net debt/EBITDA
Что обозначает Net debt/EBITDA в Clovis Oncology Inc?
Net debt/EBITDA Clovis Oncology Inc является -11.04
Какое определение для Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA компаний в Health Care сектор на NASDAQ по сравнению с Clovis Oncology Inc
Компании с net debt/ebitda похож на Clovis Oncology Inc
- M&G Plc имеет Net debt/EBITDA из -11.08
- China Yurun Food имеет Net debt/EBITDA из -11.06
- Veritex Inc имеет Net debt/EBITDA из -11.06
- Fox Marble PLC имеет Net debt/EBITDA из -11.05
- Trisura имеет Net debt/EBITDA из -11.05
- Avantium NV имеет Net debt/EBITDA из -11.04
- Clovis Oncology Inc имеет Net debt/EBITDA из -11.04
- Wayside Technology Inc имеет Net debt/EBITDA из -11.00
- Alico имеет Net debt/EBITDA из -11.00
- Maxicity имеет Net debt/EBITDA из -10.99
- Huadian Fuxin имеет Net debt/EBITDA из -10.99
- Opiant Pharmaceuticals Inc имеет Net debt/EBITDA из -10.98
- Sigma Lithium имеет Net debt/EBITDA из -10.98